Stock Rating Downgrade
The Value Trend Rating for Quest Diagnostics Inc (NYSE: DGX) weakened of late from B to C reflecting eroding fundamentals and low Appreciation Potential. Details supporting this lower rating are included in our next report.
Recent Price Action
On 9/10/24, Quest Diagnostics Inc (NYSE: DGX) stock declined slightly by -0.9%, closing at $152.86. However, this decline was accompanied by below average trading volume at 76% of normal. Relative to the market the stock has been strong over the last nine months but has declined -2.6% during the last week.
Current PriceTarget Research Rating
DGX is expected to continue to be an important Value Builder reflecting capital returns that are forecasted to be above the cost of capital.
Quest Diagnostics has a current Value Trend Rating of C (High Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing inconsistent signals. Quest Diagnostics has a neutral Appreciation Score of 50 but a good Power Rating of 75, producing the High Neutral Value Trend Rating.
Be the first to comment